These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10151732)

  • 1. FDA says 'Look at the facts' when judging its record on drug approvals.
    Gatty B
    Formulary; 1995 Jul; 30(7):412, 411. PubMed ID: 10151732
    [No Abstract]   [Full Text] [Related]  

  • 2. Making medical progress. A look at FDA approvals in 2000.
    FDA Consum; 2001; 35(2):7-8. PubMed ID: 11444251
    [No Abstract]   [Full Text] [Related]  

  • 3. New drug approvals: shifting the focus from speed to safety.
    Fulton A
    AHIP Cover; 2007; 48(5):14, 66. PubMed ID: 17941570
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA drug approvals in 1993-94.
    Wynn RL
    Gen Dent; 1995; 43(1):12, 14. PubMed ID: 7758913
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA drug approvals from 1994 to 1995.
    Wynn RL
    Gen Dent; 1996; 44(2):114, 116, 118. PubMed ID: 8690259
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA new drug approvals in 2005.
    Wynn RL
    Gen Dent; 2006; 54(4):230-3. PubMed ID: 16903192
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA new drug approvals in 2007.
    Wynn RL
    Gen Dent; 2008; 56(6):506-10. PubMed ID: 18810906
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA new drug approvals in 2006.
    Wynn RL
    Gen Dent; 2007; 55(4):275-9. PubMed ID: 17682633
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA new drug approvals in 2004.
    Wynn RL
    Gen Dent; 2005; 53(4):246-8. PubMed ID: 16158789
    [No Abstract]   [Full Text] [Related]  

  • 10. Significant FDA approvals in 1994.
    Rheinstein PH
    Am Fam Physician; 1995 Mar; 51(4):888-90. PubMed ID: 7887364
    [No Abstract]   [Full Text] [Related]  

  • 11. Significant FDA approvals in 2000.
    McGinnis TJ
    Am Fam Physician; 2001 May; 63(10):2061-4. PubMed ID: 11388719
    [No Abstract]   [Full Text] [Related]  

  • 12. What ails the FDA?
    Jenny-Avital ER
    N Engl J Med; 2005 Jun; 352(24):2554-5. PubMed ID: 15962407
    [No Abstract]   [Full Text] [Related]  

  • 13. Significant FDA approvals in 1996.
    Rheinstein PH
    Am Fam Physician; 1997 Jun; 55(8):2855-8. PubMed ID: 9191461
    [No Abstract]   [Full Text] [Related]  

  • 14. Perspectives. Approval process a moving target in FDA reform hearings.
    Rhein R
    Faulkner Grays Med Health; 1996 Feb; 50(8):suppl 1-4. PubMed ID: 10154482
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA consolidates review process for new pharmaceuticals.
    FDA Consum; 2002; 36(6):2. PubMed ID: 12523280
    [No Abstract]   [Full Text] [Related]  

  • 16. The drive to reform the FDA gains momentum.
    Gatty B
    Hosp Formul; 1995 Mar; 30(3):178, 177. PubMed ID: 10141250
    [No Abstract]   [Full Text] [Related]  

  • 17. Significant FDA approvals in 2001.
    McGinnis TJ
    Am Fam Physician; 2002 Jun; 65(11):2377-8, 2380, 2383. PubMed ID: 12074535
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA approach to generics may be a mixed blessing.
    Sipkoff M
    Manag Care; 2008 Feb; 17(2):20-1. PubMed ID: 18361252
    [No Abstract]   [Full Text] [Related]  

  • 19. Significant FDA approvals in 1995.
    Rheinstein PH
    Am Fam Physician; 1996 Apr; 53(5):1871-4. PubMed ID: 8623703
    [No Abstract]   [Full Text] [Related]  

  • 20. 1992 FDA drug approvals.
    Wynn RL
    Gen Dent; 1993; 41(4):286-7. PubMed ID: 8262339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.